Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal F | Contract | $587,778.40 | Clinical Trial | Cori Daines | Asthma/Airway Disease Rsch Ctr | Vertex Pharmaceuticals, Incorporated | 03/2022 |
| A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability Profile of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronc | Contract | $111,966.00 | Clinical Trial | Ranjit Kylathu | Pediatrics | Airway Therapeutics, Inc. | 03/2022 |
| A Phase 1-2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (The Harmony Study) | Contract | $12,285.00 | Clinical Trial | Heather Cassell | Asthma/Airway Disease Rsch Ctr | Alladapt Immunotherapeutics, Inc. | 03/2022 |
| A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) | Contract | $2,233,264.00 | Clinical Trial | Sally Suliman | COM Phx Internal Medicine | Genentech, Incorporated | 03/2022 |
| REU Site: The National Summer Undergraduate Research Project | Grant | $935,426.00 | Research Training | Michael Johnson | Immunobiology | National Science Foundation | 02/2022 |
| Neurological effects of toxic metal exposure in model rodents collected in zones of industrial agriculture on the U.S.-Mexico border | Fellowship | $140,701.00 | Research Training | Jonathan Credo | Community Environment & Policy | National Institutes of Health | 02/2022 |
| Defining the role of PIM kinases in hypoxia-induced prostate cancer invasion | Fellowship | $92,072.00 | Research Training | Corbin Jensen | Cellular & Molecular Medicine | National Cancer Institute | 02/2022 |
| Thrombocyte Regulation of Anti-Parasite Immunity | Grant | $767,500.00 | Research | Alfred Bothwell | Immunobiology | National Institute of Allergy and Infectious Disease | 02/2022 |
| The Role of the P450 Eicosanoids in the Development of Hydrocephalus | Grant | $50,000.00 | Research | Justin Cetas | Neurosurgery | Hydrocephalus Association | 02/2022 |
| Targeting Lysosomal Vulnerabilities in Renal Pathogenesis | Grant | $2,404,165.00 | Research | Steffan Nawrocki | Medicine | National Cancer Institute | 02/2022 |
| PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial | Grant | $7,674,939.00 | Research | Roberta Brinton | UAHS Brain Science | National Institutes of Health | 02/2022 |
| Journey to Mars: Pharmaceutics for deep-space explorations | Grant | $10,000.00 | Research | Jerome Lacombe | COM Phx NanoBioscience & Med | French American Cultural Exchange | 02/2022 |
| Independent Hemocompatibility Assessment of ABIOMED Mechanical Circulatory Support Devices: Hemolysis and Platelet Activation Studies | Contract | $600,000.00 | Research | Marvin Slepian | UAHS Research | ABIOMED, Inc. | 02/2022 |
| Impact of Occult Autoimmune ILD on outcomes in IPF | Contract | $29,000.00 | Research | Marilyn Glassberg Csete | COM Phx Internal Medicine | Genentech, Incorporated | 02/2022 |
| Focal Adhesion Kinase - Tumor Biology and Therapeutics | Grant | $1,626,634.00 | Research | Timothy Marlowe | COM Phx Internal Medicine | National Cancer Institute | 02/2022 |
| A Randomized Phase II Trial of the Altering Intake, Managing Symptoms (AIMS) Intervention for Bowel Dysfunction in Rectal Cancer Survivors | Grant | $93,773.00 | Research | Cynthia Thomson | Health Promotion Sciences | Beckman Research Institute of The City of Hope | 02/2022 |
| ATHN 10: Leveraging the ATHNdataset to Document the State of Rare Coagulation Disorders in the United States | Contract | $900.00 | Other Sponsored Activity | Ravitharan Krishnadasan | Medicine | American Thrombosis and Hemostasis Network | 02/2022 |
| Serum Protein-Based Indices for the Progression of Fracture Healing and Nonunion | Contract | $42,700.00 | Clinical Trial | Jason Lowe | Orthopedic Surgery | Johns Hopkins University | 02/2022 |
| Reference Range and Clinical Performance Evaluation of Elecsys IL-6 Assay in Neonatal Sepsis (US); Collection Study. | Contract | $16,584.52 | Clinical Trial | Ranjit Kylathu | Pediatrics | Icon Clinical Research, Incorporated | 02/2022 |
| Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi- Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes (BRAVO | Contract | $621,067.52 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | Ophirex | 02/2022 |
| Prospective Clinical Trial to Detect Liver Cancer through Quantification of cfDNA Methylation in Blood Samples (CLiMB) | Contract | $381,978.48 | Clinical Trial | Geoffrey Block | Liver Research Institute | Helio Health | 02/2022 |
| Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns with Neonatal Opioid Withdrawal Syndrome (NOWS) | Contract | $285,720.00 | Clinical Trial | Ranjit Kylathu | Pediatrics | RTI International | 02/2022 |
| Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (The PROMISE II Trial) | Contract | $251,024.00 | Clinical Trial | Wei Zhou | Surgery | LimFlow, Inc. | 02/2022 |
| INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer, a Phase II Randomized Multi-center Trial With and Without APX005M, an Anti-CD40 Agonist | Contract | $70,892.00 | Clinical Trial | Aaron Scott | Cancer Center Division | University of Texas Southwestern Medical Center | 02/2022 |
| Assessment of the CARILLON Mitral Contour System in Treating Functional Mitral Regurgitation Associated with Heart Failure | Contract | $274,041.75 | Clinical Trial | Kwan Lee | Sarver Heart Center | Cardiac Dimensions, Inc. | 02/2022 |